BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 10064246)

  • 1. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
    Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial response: A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.
    Larsen RA
    Clin Infect Dis; 1999 Feb; 28(2):297-8. PubMed ID: 10064247
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
    Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF
    N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G; Di Lorenzo G
    Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
    Bozzette SA; Larsen RA; Chiu J; Leal MA; Jacobsen J; Rothman P; Robinson P; Gilbert G; McCutchan JA; Tilles J
    N Engl J Med; 1991 Feb; 324(9):580-4. PubMed ID: 1992319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-Nübling G
    Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
    Lortholary O; Poizat G; Zeller V; Neuville S; Boibieux A; Alvarez M; Dellamonica P; Botterel F; Dromer F; Chêne G
    AIDS; 2006 Nov; 20(17):2183-91. PubMed ID: 17086058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
    Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK
    Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
    Jaruratanasirikul S
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of itraconazole with initial flucytosine in AIDS-related cryptococcal meningitis: a preliminary study.
    Riantawan P; Ponglertnapakorn P
    J Med Assoc Thai; 1996 Jul; 79(7):429-33. PubMed ID: 8855621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G; Barbarini G; Di Lorenzo G
    Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
    Barbaro G; Barbarini G; Di Lorenzo G
    Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    McKinsey DS; Wheat LJ; Cloud GA; Pierce M; Black JR; Bamberger DM; Goldman M; Thomas CJ; Gutsch HM; Moskovitz B; Dismukes WE; Kauffman CA
    Clin Infect Dis; 1999 May; 28(5):1049-56. PubMed ID: 10452633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole.
    Schaars CF; Meintjes GA; Morroni C; Post FA; Maartens G
    BMC Infect Dis; 2006 Jul; 6():118. PubMed ID: 16846523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole therapy for cryptococcal meningitis and cryptococcosis.
    Denning DW; Tucker RM; Hanson LH; Hamilton JR; Stevens DA
    Arch Intern Med; 1989 Oct; 149(10):2301-8. PubMed ID: 2552949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.